Cella Space (532701)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading below book value: price ₹13.77 versus book value ₹15.73, P/B of 0.88
• Small market cap of ₹28 Cr may offer asset-backed downside support if book value holds
• P/E of 10.77 is not demanding on trailing earnings, though earnings quality is weak

Concerns

• Sales declined 29.41% and latest quarter shows near-zero revenue and profit
• Profit growth of -286.96% indicates severe deterioration, likely a net loss
• Piotroski F-Score of 3/9 suggests poor financial health and operational weakness
• No dividend and insufficient disclosure on promoter holding raise governance questions

AI Analysis

At ₹13.77, Cella Space trades below its book value of ₹15.73, which initially catches a Graham-style eye. But value investing is not just buying cheap; it is buying good businesses at a fair price, or at least solid assets with a margin of safety. This is a micro-cap paper products company with a market cap of just ₹28 crore, and the latest quarter shows essentially zero sales and zero net profit. Full-year sales fell 29.41%, and profit growth is down 286.96%—that suggests a business that has moved from profits into losses, not a temporary stumble. Return on equity is only 6.22%, and ROCE is 5.99%; for a small cap with no pricing power, these returns do not clear an acceptable hurdle. The Piotroski F-Score of 3 out of 9 is a red flag: weak profitability, likely deteriorating margins and balance-sheet strain. There is no dividend to compensate shareholders while waiting. I would not call this a franchise with an economic moat; paper is a commodity, and without scale or cost advantage, this is a marginal operation. The only positive is asset backing: the share sits at 0.88 times book, so the market is already discounting the balance sheet. But that discount may be justified if assets cannot generate earnings. For a disciplined investor, this is not a quality compounder. It is a possible asset play, at best, requiring deep diligence into liquidation value, hidden liabilities, and management’s capital allocation. I would need strong evidence of a genuine turnaround—meaning real sales and positive cash flows—before committing. The price is low, but low price alone is not enough. Numerically, this resembles a value trap until proven otherwise.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer